Dieterich, Douglas T.

Publishing since 1986 (Dinosaur)

Has published 86 publications in 24 years

Number of publications published per year by Dieterich, Douglas T.. (Source : PubMed)

Distribution of publications types for Dieterich, Douglas T.. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Dieterich DT, Rizzetto M, Manns MP. Management of chronic hepatitis C patients who have relapsed or not responded to pegylated interferon alfa plus ribavirin.  J. Viral Hepat.  2009;16;12  
•  Holness G, Carriero DC, Dieterich DT. Hepatitis B therapies and antiviral resistance detection and management.  Expert review of gastroenterology & hepatology  2009;3;6  
•  Keeffe EB, Dieterich DT, Han SH, Jacobson IM, Martin P, Schiff ER, Tobias H. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update.  Clin. Gastroenterol. Hepatol.  2008;6;12  
•  Fierer DS, Uriel AJ, Carriero DC, Klepper A, Dieterich DT, Mullen MP, Thung SN, Fiel MI, Branch AD. Liver fibrosis during an outbreak of acute hepatitis C virus infection in HIV-infected men: a prospective cohort study.  J. Infect. Dis.  2008;198;5  
•  Weiss JJ, Bhatti L, Dieterich DT, Edlin BR, Fishbein DA, Goetz MB, Yu K, Wagner GJ. Hepatitis C patients' self-reported adherence to treatment with pegylated interferon and ribavirin.  Aliment. Pharmacol. Ther.  2008;28;3  
•  Rodríguez-Torres M, Govindarajan S, Solá R, Clumeck N, Lissen E, Pessôa M, Buggisch P, Main J, Depamphilis J, Dieterich DT. Hepatic steatosis in HIV/HCV co-infected patients: correlates, efficacy and outcomes of anti-HCV therapy: a paired liver biopsy study.  J. Hepatol.  2008;48;5  
•  Weiss JJ, Bhatti L, Dieterich DT, Edlin BR, Fishbein DA, Goetz MB, Yu K, Wagner GJ. Hepatitis C patients' self-reported adherence to pegylated interferon and ribavirin.  Aliment. Pharmacol. Ther.  2008  
•  Carriero D, Fabrizi F, Uriel AJ, Park J, Martin P, Dieterich DT. Treatment of dialysis patients with chronic hepatitis C using pegylated interferon and low-dose ribavirin.  Int J Artif Organs  2008;31;4  
•  Keeffe EB, Dieterich DT, Pawlotsky JM, Benhamou Y. Chronic hepatitis B: preventing, detecting, and managing viral resistance.  Clin. Gastroenterol. Hepatol.  2008;6;3  
•  Opravil M, Sasadeusz J, Cooper DA, Rockstroh JK, Clumeck N, Clotet B, Montaner J, Torriani FJ, Depamphilis J, Dieterich DT. Effect of baseline CD4 cell count on the efficacy and safety of peginterferon Alfa-2a (40KD) plus ribavirin in patients with HIV/hepatitis C virus coinfection.  J. Acquir. Immune Defic. Syndr.  2008;47;1  

[ See timeline ] [ See all publications ]